The National Institutes of Health Clinical Center has suspended operation of its Pharmaceutical Development Section in Bethesda. The move follows an inspection by the Food and Drug Administration that was prompted by a whistleblower. Inspectors found a series of operating and handling deficiencies, including experimental drugs contaminated with fungus. Dr. Lawrence Tabak joined Tom Temin on the Federal Drive with more on what NIH found and what it’s doing to fix the problem.

Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.